Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about REPLIGEN CORPORATION
01/12Repligen Seeks Acquisitions
CI
01/04Repligen Corporation Promotes James Bylund to the Chief Operating Officer and Principal..
CI
2021Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
AQ
2021Repligen Corporation acquired Bio-Flex Solutions, L.L.C. / Newton T & M Corp.
CI
2021INSIDER SELL : Repligen
MT
2021INSIDER SELL : Repligen
MT
2021Repligen Corporation to Present at Upcoming Investor Conferences
GL
2021Repligen Releases Inaugural Sustainability Report
AQ
2021Repligen Releases Inaugural Sustainability Report
AQ
2021INSIDER SELL : Repligen
MT
2021INSIDER SELL : Repligen
MT
2021SVB Leerink Adjusts Price Target on Repligen to $325 from $260, Keeps Outperform Rating
MT
2021Repligen Corporation Reports Earnings Results for the Third Quarter and Nine Months End..
CI
2021Tranche Update on Repligen Corporation's Equity Buyback Plan announced on June 18, 2008..
CI
2021Repligen Q3 Adjusted Earnings, Revenue Jump; Company Lifts 2021 Outlook
MT
More most relevant news
All news about REPLIGEN CORPORATION
01/12Repligen Seeks Acquisitions
CI
01/04REPLIGEN CORP : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
01/04Repligen Corporation Promotes James Bylund to the Chief Operating Officer and Principal..
CI
2021Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
AQ
2021REPLIGEN CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
AQ
2021Repligen Corporation acquired Bio-Flex Solutions, L.L.C. / Newton T & M Corp.
CI
2021INSIDER SELL : Repligen
MT
2021Technically solid
2021INSIDER SELL : Repligen
MT
2021Repligen Corporation to Present at Upcoming Investor Conferences
GL
More news
News in other languages on REPLIGEN CORPORATION
01/12Repligen cherche à faire des acquisitions
01/04Repligen Corporation promeut James Bylund au poste de directeur de l'exploitation et de..
2021VENTE D'INITIÉS : Repligen
2021VENTE D'INITIÉS : Repligen
2021VENTE D'INITIÉS : Repligen
2021REPLIGEN : hausse du bénéfice ajusté et du chiffre d'affaires au 3e trimestre et relèvemen..
2021Repligen Corporation fournit des prévisions de résultats pour l'exercice 2021
2021Earnings Flash (RGEN) REPLIGEN CORPORATION affiche un chiffre d'affaires de 178,2 milli..
2021Los valores del Nasdaq con mayor crecimiento
2021Les actions du Nasdaq avec la plus forte croissance
More news
Analyst Recommendations on REPLIGEN CORPORATION
2021SVB Leerink Adjusts Price Target on Repligen to $325 from $260, Keeps Outperform Rating
MT
2021REPLIGEN : Exane BNP Paribas Starts Repligen at Outperform with $330 Price Target
MT
2021REPLIGEN : Craig Hallum Adjusts Repligen PT to $368 From $258, Maintains Buy Rating
MT
2021REPLIGEN : KeyBanc Raises Price Target on Repligen to $335 From $255, Keeps Overweight Rat..
MT
2021REPLIGEN : Stephens Adjusts Repligen's Price Target to $290 From $255, Maintains Overweigh..
MT
More recommendations
Press releases
01/04REPLIGEN CORP : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
2021Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
AQ
2021REPLIGEN CORP : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
AQ
2021Repligen Corporation to Present at Upcoming Investor Conferences
GL
2021Repligen Releases Inaugural Sustainability Report
AQ
More press releases
Upcoming event on REPLIGEN CORPORATION
02/24/22